End to End Regulatory Affairs Services for Life Sciences

Regulatory Affairs. Done Right.

Regulatory affairs is a specialist field developed to protect public health by ensuring the safety, efficacy and quality of pharmaceutical, biotech, gene therapy and medical device products. After the significant investment of bringing a product through development, it is essential to ensure you have the right regulatory strategy in place to protect that investment and accelerate your route to market.

At BioReg Life Sciences our decades of experience across global regulatory affairs, combined with our end to end service capability, enables us to develop and execute the most effective regulatory strategy for your product and your business. From Phase 2 onwards we work alongside you — providing expert guidance, hands on support and full submission management across FDA, EMA, MHRA and global markets.

From initial gap analysis and regulatory roadmap through to eCTD publishing, submission management and lifecycle maintenance, we are your complete regulatory partner — helping you navigate the complexity of global compliance and get your science to the patients who need it

Regulatory Affairs Guidance &
Stategy from your early phases

The biggest regulatory mistakes don't happen at submission — they happen long before it, when companies move forward without a clear strategy or an honest picture of where they stand. Most companies leave this conversation too late and it costs them dearly

At BioReg Life Sciences we partner with biotech, gene therapy, medical device and life sciences companies from Phase 2 onwards to make sure that never happens to you. We conduct thorough gap analyses, build tailored regulatory strategies and define the optimal pathway to approval across FDA, EMA, MHRA and global markets. We provide expert guidance on GMP requirements, labelling standards, document templates and country specific regulatory expectations — covering everything from early strategic planning through to Module 1 and Module 2 document preparation.

Document Preparation

A regulatory submission is only as strong as the documents behind it. Poorly structured, incomplete or non-compliant documentation is one of the leading causes of regulatory delays, authority queries and costly rejections — setbacks that growing life sciences companies simply cannot afford.

At BioReg Life Sciences we take complete ownership of your regulatory document preparation. Our experienced team structures, writes and formats your Module 1 and Module 2 documentation to the highest standard, ensuring full compliance with FDA, EMA, MHRA and global regulatory requirements. Every document we produce is accurate, submission ready and built to withstand regulatory scrutiny.

Beyond preparation, we manage your full document lifecycle through our secure document management system — version control, audit trails and centralised storage all taken care of. When your documents are in our hands, nothing gets missed and nothing gets left to chance.

Lifecycle Management

Regulatory approval is not the finish line — it is the beginning of an ongoing compliance commitment. Post approval, your product must remain continuously compliant through variations, renewals, labelling updates, safety reporting and regular interactions with regulatory authorities. For many companies this is where the cracks start to appear.

At BioReg Life Sciences we manage your complete regulatory lifecycle so they never do. From post approval variations and PSUR submissions to authority query management and product renewals, we handle every obligation with the same precision we bring to initial submissions. Your full regulatory dossier is securely hosted in our managed document system, giving you continuous access to your submission history and compliance records at all times.

With BioReg Life Sciences managing your lifecycle, your product stays compliant, your team stays focused and your business keeps moving forward.

eCTD Publishing Services

When it comes to regulatory submissions there is no margin for error. A single technical failure, validation issue or formatting mistake can delay your approval by months — and in the life sciences world, time is everything.

At BioReg Life Sciences eCTD publishing is at the heart of what we do. With over 5,000 submissions completed and a 100% acceptance rate, we bring an unmatched level of precision, experience and reliability to every dossier we publish. Using industry leading Freyr software we compile, hyperlink, validate and quality check your complete eCTD submission to ensure full technical compliance with FDA, EMA, MHRA and all major global health authorities.

From your first IND or CTA through to a full NDA or MAA, we deliver submissions that are complete, compliant and accepted — on time, every time. Because when you've invested everything in getting to this point, the submission has to be right.

How we work with you.

Project Basis

We become your external regulatory partner — delivering end-to-end guidance from roadmap to submission.

Fixed scope • Clear pricing • Full accountability

- Fixed scope of work with clearly defined, transparent pricing

- Senior-led delivery with full accountability at every stage

- Scalable support across single or multiple products and markets

- Secure long-term DMS hosting and submission management

- End-to-end regulatory coverage from gap analysis to post-approval maintenance

- Ideal for: Companies who need delivery without increasing internal headcount

Vendor Partnership

We embed senior regulatory specialists directly into your team as seamless extensions of your organisation.

• Hands-on support • Knowledge Transfer • Retainer basis

- Immediate access to deep technical expertise with no onboarding lag

- Seamless integration into your internal systems, tools and processes

- Full representation as internal team members to clients and authorities

- Flexible capacity to absorb high workload peaks without disruption

- Knowledge transfer and capability building within your organisation

- Ideal for: Teams facing workload peaks or capability gaps without hiring

Embedded Consultant

A single defined piece of regulatory work — delivered brilliantly with no ongoing commitment

Fixed fee • Low risk • Clear deliverables

- Low-risk entry point for new clients

- Fixed fee with clearly scoped deliverables - Senior-led delivery with no hidden costs - Ideal for gap analysis, dossier review, one-off submissions or template packs

- Ideal for: Companies who want to test our expertise before committing to a larger engagement

Why choose BioReg Life Sciences.

When you partner with us, you get senior expertise with direct accountability — no junior hand-offs, no account management layers, just experienced regulatory professionals who own your project from start to finish.

With over 40 years of combined experience, 5,000+ submissions and a 100% acceptance rate across MHRA, EMA and FDA, we deliver results that speak for themselves.Unlike larger CROs where clients become project numbers, we provide a dedicated end-to-end service — from regulatory strategy and gap analysis through to eCTD publishing, submission management and long-term lifecycle maintenance. Our clients typically reduce their internal regulatory burden by 70-80% and reach market 3-6 months faster than going it alone.

Whether you need a Vendor Partnership, an Embedded Consultant or a simple Project Based engagement, we have a transparent pricing model that works for you.Regulatory Affairs. Done Right.

Regulatory Affairs. Done Right.

​

Regulatory Affairs Guidance & Stategy from your early phases

Project Basis

Vendor Partnership

Embedded Consultant

Regulatory Affairs Guidance &
Stategy from your early phases